LingSing Chen, PhD, former VP and Global Head of Translational Medicine and Biosimilars at QPS, shares her bioanalytical expertise in a new eBook published by Future Science’s Bioanalysis Journal. The book — Bioanalysis for Biosimilars Development — went live this week.
Dr. Chen’s contribution is Chapter 2, an overview of biosimilars development. In this section, she outlines the requirements for comparative and biosimilarity testing between the innovator reference products and biosimilars. Topics covered include product quality attributes, nonclinical and clinical studies, and current regulatory guidelines for biosimilar product development.
Do we ever love to see our scientists stretching their wings! Especially for everyone’s benefit.